Nassar D, Soutou B, Aractingi S
Hôpital Tenon, Service de dermatologie-allergologie, 4, rue de la Chine, 75020 Paris, France.
Bull Cancer. 2009 Dec;96 Suppl:S85-91. doi: 10.1684/bdc.2009.1000.
EGFR receptor inhibitors are used for the treatment of a number of solid tumors. Their cutaneous toxicity is a specific and frequent side effect that has shown to be correlated to the antitumoral effect. Here, we present an overview of the cutaneous manifestations and management of EGF receptor inhibitors toxicity.
表皮生长因子受体（EGFR）抑制剂被用于治疗多种实体瘤。其皮肤毒性是一种特殊且常见的副作用，已证明与抗肿瘤作用相关。在此，我们概述表皮生长因子受体抑制剂毒性的皮肤表现及处理方法。
